MEPs clash over EU’s new pharma strategy MEPs clash over EU’s new pharma strategy Pharmaceutical strategy aims to boost EU drug discovery and prevent medicines shortages. Some MEPs want to go further and force companies to invest more of their profits in R&D and agree to flexible IP rules. Others say that is ‘tone deaf’ 27 May 2021 R&D Policy
Pharma group calls for ramping up of contingency plans, as vote takes UK to brink of no-deal Brexit Pharma group calls for ramping up of contingency plans, as vote takes UK to brink of no-deal Brexit Industry says regulators must intensify preparations for a worst-case scenario. ‘Time is almost up’, warns European Commission president 17 Jan 2019 News